A North Carolina woman says she ended up in the emergency room after overdosing on a GLP-1 weight-loss drug that had been prescribed through a telehealth company. According to the report, she followed the dosage instructions she was given before suffering the overdose.

The case comes as demand for GLP-1 medications continues to surge across the United States. Many patients seeking help with weight loss are turning to telehealth providers for faster and easier access to these high-profile drugs, which have become some of the most sought-after treatments on the market.

Her experience is drawing attention to a key concern: whether remote prescribing models provide enough guidance on dosing, monitoring and side effects for powerful medications like GLP-1 drugs. The report highlights broader questions about how safely these prescriptions are being handled when patients rely on online services instead of in-person care.

As more Americans use telehealth to obtain weight-loss medications, the incident adds to scrutiny around oversight and patient education. It also underscores the potential risks when instructions are unclear or treatment is not closely supervised.